Botfet / Company detail

LLY

approved

Lilly (Eli)

biotech

Moat score82out of 100

The numbers

Financial metrics

Quality gate and thesis context

Roic30.2%

Gross Margin83.0%

Revenue Cagr23.2%

Fcf Conversion43.5%

Fcf Yield0.7%

Interest Coverage39.9x

Market Cap B$1205.8B

Pe42.6

Quality PassPass

Founder LedNo

Thesis AlignedYes

Moat Quant54

Why it may endure

Moat breakdown

Quant: 54 · Curator: 28

Market Share Stability6

Network Effects6

Pricing Power20

Regulatory Moat16

Switching Costs6

Conviction10/10

Leadership9/10

Vision9/10

← Back to the full screener